GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo

We have previously demonstrated that estrogen receptor (ER) alpha (ESR1) increases proliferation of adrenocortical carcinoma (ACC) through both an estrogen-dependent and -independent (induced by IGF-II/IGF1R pathways) manner. Then, the use of tamoxifen, a selective estrogen receptor modulator (SERM)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chimento, Adele, Sirianni, Rosa, Casaburi, Ivan, Zolea, Fabiana, Rizza, Pietro, Avena, Paola, Malivindi, Rocco, De Luca, Arianna, Campana, Carmela, Martire, Emilia, Domanico, Francesco, Fallo, Francesco, Carpinelli, Giulia, Cerquetti, Lidia, Amendola, Donatella, Stigliano, Antonio, Pezzi, Vincenzo
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662484/
https://ncbi.nlm.nih.gov/pubmed/26131713
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars